Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

SCHIFF, RACHEL

One or more keywords matched the following items that are connected to SCHIFF, RACHEL

Item Type	Name
Academic Article	Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
Academic Article	Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.
Academic Article	Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.
Academic Article	Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.
Academic Article	Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.
Academic Article	Estrogen-receptor biology: continuing progress and therapeutic implications.
Academic Article	Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase.
Academic Article	Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.
Academic Article	Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Academic Article	Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.
Academic Article	Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.
Academic Article	More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response.
Academic Article	Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.
Academic Article	Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.
Academic Article	Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer.
Academic Article	Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.
Academic Article	Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.
Concept	Tamoxifen
Academic Article	Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production.
Academic Article	Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance.
Academic Article	An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
Academic Article	Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.
Academic Article	Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
Academic Article	Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.
Academic Article	FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
Academic Article	The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer.
Academic Article	Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
Academic Article	Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis.
Academic Article	AhR ligand aminoflavone suppresses a6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.
Academic Article	The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance.
Academic Article	Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance.
Academic Article	The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
Academic Article	Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.
Academic Article	Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.
Academic Article	NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer.
Academic Article	A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.

Search Criteria

Tamoxifen